Cardiogenetics (Jul 2022)

Association of <i>GSTT1</i>, <i>GSTM1</i> and <i>GSTP1 (Ile105Val)</i> mRNA Expression with Cardiometabolic Risk Parameters in Women with Breast Cancer and Comorbidities

  • Yizel Becerril Alarcón,
  • Fernando Bastida González,
  • Isidro Roberto Camacho Beiza,
  • Eduardo Dávila González,
  • José Alfonso Cruz Ramos,
  • Alejandra Donají Benítez Arciniega,
  • Roxana Valdés Ramos,
  • Alexandra Estela Soto Piña

DOI
https://doi.org/10.3390/cardiogenetics12030022
Journal volume & issue
Vol. 12, no. 3
pp. 235 – 245

Abstract

Read online

Breast cancer (BC) and cardiometabolic diseases share a multifactorial and modifiable etiology, modulated by complex molecular pathways. Glutathione S-transferase (GST) plays a critical role, providing protection against xenobiotics and regulating levels of enzymes and proteins in the cell. GST variants have a significant impact on susceptibility to diseases whose pathogenesis involves oxidative stress, as is the case in many inflammatory diseases such as BC and cardiometabolic pathologies. However, the expression of these polymorphic variants has not been studied in BC. This study aimed to evaluate the presence of GST mRNA isoforms and their association with clinical and cardiometabolic parameters in women with BC. This was a case-control study, and a total of 57 participants were recruited. Concentrations of glucose and lipids in blood were measured in all the participants. GST variants (GSTT1, GSTM1 and GSTP1 Ile105Val polymorphism) were evaluated in all the participants by real-time PCR analysis. There was a significant association (p GSTP1 and LDL-c in the BC group. However, the control group showed significant associations between blood pressure with GSTT1 and GSTP1 variants with total cholesterol (TC), LDL-c, VLDL-c and triacylglycerols (TG). Therefore, GSTT1 and GSTP1 variants could be emerging biomarkers to discriminate between BC cases related or not to cardiometabolic disease factors.

Keywords